๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study

โœ Scribed by Leal, Alexis D.; Qin, Rui; Atherton, Pamela J.; Haluska, Paul; Behrens, Robert J.; Tiber, Charles H.; Watanaboonyakhet, Patanit; Weiss, Matthias; Adams, Paul T.; Dockter, Travis J.; Loprinzi, Charles L.


Book ID
121816938
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
277 KB
Volume
120
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy of gabapentin in the management
โœ Ravi D. Rao; John C. Michalak; Jeff A. Sloan; Charles L. Loprinzi; Gamini S. Soo ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 228 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. The antiepileptic agent, gabapentin, has been demonstrated to relieve symptoms of peripheral neuropathy due to various etiologies. On the basis of these data, a multicenter, doubleโ€blind, placeboโ€controlled, crossover, randomized trial was conducted to evaluate the effec